Fresenius Medical Care AG(FMS)Stock Analysis

FMS Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Fresenius Medical Care AG (FMS), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores FMS at 59.9/100 on a 32-signal composite quality model, placing it at rank #891 of 2,879 stocks — the top half of the AI-ranked universe. FMS scores in the top quartile across institutional flow (96.7), revenue scale (92.7), earnings quality (81.1). Areas of concern include free cash flow (30.0) and revenue growth (34.1), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q4 2016), Fresenius Medical Care AG reports net income of $388.1M, free cash flow of $561.2M. Top institutional holders of FMS by reported 13-F value include PZENA INVESTMENT MANAGEMENT, FIDUCIARY MANAGEMENT /WI/, DODGE & COX, based on the most recent SEC filings. FMS trades on the NYSE exchange and files with the SEC under CIK 1333141. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate FMS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Fresenius Medical Care AG directly from SEC EDGAR. Fresenius Medical Care AG's 13F Pro composite quality score has ranged between 56 and 60 since 2026, currently 59.9 — an improving long-term trajectory across 8 quarterly and live scoring snapshots.